osimertinib
astrazeneca
['tagrisso', 'adaura', 'lcsm,(-blcsm)', 'osimertinib']
"tagrisso demonstrated strong overall survival benefit in the adaura" data convincing this press release was presented in plenary session by . really need uniform access both to egfr testing and adjuvant osimertinib worldwide. #asco23 #lcsm 
Medical Oncologist, National Cancer Center Hospital, Lung Cancer Study Group @JCOG_official, Educational Committee @JSMO_official, @JLCS_OFFICIAL, @IASLC